Spartan Wealth Advisory Services’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Spartan Wealth Advisory Services's LLY Position: Q3 2026 in Review
Spartan Wealth Advisory Services increased its Eli Lilly (LLY) stake by 3.9% in Q3 2026, buying an estimated $691K and bringing the position to 15,778 shares worth $18.3M. The position accounts for 1.46% of the portfolio, ranked #12.
Spartan Wealth Advisory Services first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Spartan Wealth Advisory Services held 15,778 shares of Eli Lilly worth $18.3M as of Q3 2026.
- Spartan Wealth Advisory Services bought 586 Eli Lilly shares in Q3 2026, an estimated $691K.
- Eli Lilly made up 1.46% of Spartan Wealth Advisory Services's portfolio in Q3 2026, its #12 holding.
- Spartan Wealth Advisory Services first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Spartan Wealth Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.